Immune mechanisms of group B coxsackievirus induced viral myocarditis

ABSTRACT Viral myocarditis is known to be a primary cause of dilated cardiomyopathy (DCM) that can lead to heart failure and sudden cardiac death and is invariably caused by myocardial viral infection following active inflammatory destruction of the myocardium. Although acute viral myocarditis frequently recovers on its own, current chronic myocarditis therapies are unsatisfactory, where the persistence of viral or immunological insults to the heart may play a role. Cellular and mouse experimental models that utilized the most prevalent Coxsackievirus group B type 3 (CVB3) virus infection causing myocarditis have illustrated the pathophysiology of viral myocarditis. In this review, immunological insights into the different stages of development of viral myocarditis were discussed, concentrating on the mechanisms of innate and adaptive immunity in the development of CVB3-induced myocarditis.

[1]  Yu-jin Jeong,et al.  Extracellular nucleoprotein exacerbates influenza virus pathogenesis by activating Toll-like receptor 4 and the NLRP3 inflammasome , 2022, Cellular & Molecular Immunology.

[2]  Jingwei Dong,et al.  The absence of B cells disrupts splenic and myocardial Treg homeostasis in coxsackievirus B3-induced myocarditis. , 2022, Clinical and experimental immunology.

[3]  G. Seebohm,et al.  Virus-Host Interactions of Enteroviruses and Parvovirus B19 in Myocarditis. , 2021, Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology.

[4]  Jong-Soo Lee,et al.  Regulation of antiviral innate immune signaling and viral evasion following viral genome sensing , 2021, Experimental & Molecular Medicine.

[5]  S. Heymans,et al.  Post‐discharge arrhythmic risk stratification of patients with acute myocarditis and life‐threatening ventricular tachyarrhythmias , 2021, European Journal of Heart Failure.

[6]  A. Valaperti,et al.  Human cardiac fibroblasts produce pro-inflammatory cytokines upon TLRs and RLRs stimulation , 2021, Molecular and Cellular Biochemistry.

[7]  Yanlan Huang,et al.  The Role of B Cells in Regulation of Th Cell Differentiation in Coxsackievirus B3–Induced Acute Myocarditis , 2021, Inflammation.

[8]  Jian-Ping Zuo,et al.  NOD-like receptors in autoimmune diseases , 2021, Acta Pharmacologica Sinica.

[9]  K. Klingel,et al.  Mitigated viral myocarditis in A/J mice by the immunoproteasome inhibitor ONX 0914 depends on inhibition of systemic inflammatory responses in CoxsackievirusB3 infection , 2021, Basic Research in Cardiology.

[10]  Liu Chen,et al.  Activation of Toll‐like receptor 7 provides cardioprotection in septic cardiomyopathy‐induced systolic dysfunction , 2021, Clinical and translational medicine.

[11]  B. Prusty,et al.  Detection of parvovirus B19 and human herpesvirus 6 in pediatric dilated cardiomyopathy: Impact after heart transplantation , 2020, Annals of pediatric cardiology.

[12]  E. Fabris,et al.  Viral presence‐guided immunomodulation in lymphocytic myocarditis: an update , 2020, European journal of heart failure.

[13]  Helen Yu,et al.  Discovery of GS-9688 (Selgantolimod), as a Potent and Selective Oral Toll-like Receptor 8 Agonist for the Treatment of Chronic Hepatitis B. , 2020, Journal of medicinal chemistry.

[14]  W. Brady,et al.  Cardiovascular complications in COVID-19 , 2020, The American Journal of Emergency Medicine.

[15]  P. Kingsley,et al.  Potently Cytotoxic Natural Killer Cells Initially Emerge from Erythro-Myeloid Progenitors during Mammalian Development. , 2020, Developmental cell.

[16]  Yiwu Zhou,et al.  SARS-CoV-2: a potential novel etiology of fulminant myocarditis , 2020, Herz.

[17]  R. Klopfleisch,et al.  Development of a New Mouse Model for Coxsackievirus-Induced Myocarditis by Attenuating Coxsackievirus B3 Virulence in the Pancreas. , 2020, Cardiovascular research.

[18]  U. Eriksson,et al.  Heart non-specific effector CD4+ T cells protect from postinflammatory fibrosis and cardiac dysfunction in experimental autoimmune myocarditis , 2019, Basic Research in Cardiology.

[19]  R. Klopfleisch,et al.  Early Treatment of Coxsackievirus B3-Infected Animals With Soluble Coxsackievirus-Adenovirus Receptor Inhibits Development of Chronic Coxsackievirus B3 Cardiomyopathy. , 2019, Circulation. Heart failure.

[20]  Yanlan Huang,et al.  IL-10-producing B cells attenuate cardiac inflammation by regulating Th1 and Th17 cells in acute viral myocarditis induced by coxsackie virus B3. , 2019, Life sciences.

[21]  S. Xiong,et al.  Macrophage NLRP3 inflammasome activated by CVB3 capsid proteins contributes to the development of viral myocarditis. , 2019, Molecular immunology.

[22]  J. Ge,et al.  FTY720 alleviates coxsackievirus B3‐induced myocarditis and inhibits viral replication through regulating sphingosine 1‐phosphate receptors and AKT/caspase‐3 pathways , 2019, Journal of cellular physiology.

[23]  H. Brody.  Influenza , 2019, Nature.

[24]  Xuetao Cao,et al.  E3 ubiquitin ligase RNF170 inhibits innate immune responses by targeting and degrading TLR3 in murine cells , 2019, Cellular & Molecular Immunology.

[25]  Y. He,et al.  Effect of IL-6-mediated STAT3 signaling pathway on myocardial apoptosis in mice with dilated cardiomyopathy. , 2019, European Review for Medical and Pharmacological Sciences.

[26]  Tianlong Liu,et al.  Astragalus polysaccharide from Astragalus Melittin ameliorates inflammation via suppressing the activation of TLR-4/NF-κB p65 signal pathway and protects mice from CVB3-induced virus myocarditis. , 2019, International journal of biological macromolecules.

[27]  K. Klingel,et al.  Blocking the IL-1β signalling pathway prevents chronic viral myocarditis and cardiac remodeling , 2019, Basic Research in Cardiology.

[28]  Yanlan Huang,et al.  B Cells Increase Myocardial Inflammation by Suppressing M2 Macrophage Polarization in Coxsackie Virus B3-Induced Acute Myocarditis , 2019, Inflammation.

[29]  Yanlan Huang,et al.  B Cells Increase Myocardial Inflammation by Suppressing M2 Macrophage Polarization in Coxsackie Virus B3-Induced Acute Myocarditis , 2019, Inflammation.

[30]  R. Gómez,et al.  Role of neutrophils in CVB3 infection and viral myocarditis. , 2018, Journal of molecular and cellular cardiology.

[31]  Wei Xu,et al.  TRIM21 Restricts Coxsackievirus B3 Replication, Cardiac and Pancreatic Injury via Interacting With MAVS and Positively Regulating IRF3-Mediated Type-I Interferon Production , 2018, Front. Immunol..

[32]  Daniel G. Anderson,et al.  Silencing the CSF-1 Axis Using Nanoparticle Encapsulated siRNA Mitigates Viral and Autoimmune Myocarditis , 2018, Front. Immunol..

[33]  Li Yue-chun,et al.  The cholinergic anti-inflammatory pathway ameliorates acute viral myocarditis in mice by regulating CD4+ T cell differentiation , 2018, Virulence.

[34]  Chiung-Ya Chen,et al.  Endosomal TLR3, TLR7, and TLR8 control neuronal morphology through different transcriptional programs , 2018, The Journal of cell biology.

[35]  M. Rosenblum,et al.  Fas ligand promotes an inducible TLR‐dependent model of cutaneous lupus‐like inflammation , 2018, The Journal of clinical investigation.

[36]  D. Mann,et al.  Modulation of subsets of cardiac B lymphocytes improves cardiac function after acute injury. , 2018, JCI insight.

[37]  Lili Xiao,et al.  Progranulin ameliorates coxsackievirus‐B3‐induced viral myocarditis by downregulating Th1 and Th17 cells , 2018, Experimental cell research.

[38]  Lifang Zhao,et al.  Roles of Host Immunity in Viral Myocarditis and Dilated Cardiomyopathy , 2018, Journal of immunology research.

[39]  S. Blankenberg,et al.  The forkhead transcription factor Foxo3 negatively regulates natural killer cell function and viral clearance in myocarditis , 2018, European heart journal.

[40]  R. Mariuzza,et al.  Identification of the fungal ligand triggering cytotoxic PRR-mediated NK cell killing of Cryptococcus and Candida , 2018, Nature Communications.

[41]  P. Most,et al.  Pathogenic Role of the Damage-Associated Molecular Patterns S100A8 and S100A9 in Coxsackievirus B3–Induced Myocarditis , 2017, Circulation. Heart failure.

[42]  N. Ntusi.  HIV and myocarditis , 2017, Current opinion in HIV and AIDS.

[43]  H. Kutzner,et al.  Detection of human parvovirus B19 DNA in 22% of 1815 cutaneous biopsies of a wide variety of dermatological conditions suggests viral persistence after primary infection and casts doubts on its pathogenic significance , 2017, The British journal of dermatology.

[44]  A. Xu,et al.  TRIF-dependent Toll-like receptor signaling suppresses Scd1 transcription in hepatocytes and prevents diet-induced hepatic steatosis , 2017, Science Signaling.

[45]  M. Mohsenzadegan,et al.  The role of JAK-STAT signaling pathway and its regulators in the fate of T helper cells , 2017, Cell Communication and Signaling.

[46]  Jing Yuan,et al.  Coxsackievirus B3 Directly Induced Th17 Cell Differentiation by Inhibiting Nup98 Expression in Patients with Acute Viral Myocarditis , 2016, Front. Cell. Infect. Microbiol..

[47]  S. Heymans,et al.  A novel 72-kDa leukocyte-derived osteoglycin enhances the activation of toll-like receptor 4 and exacerbates cardiac inflammation during viral myocarditis , 2016, Cellular and Molecular Life Sciences.

[48]  David J. Marchant,et al.  Emerging pharmacologic targets and treatments for myocarditis. , 2016, Pharmacology & therapeutics.

[49]  S. Huber.  Viral Myocarditis and Dilated Cardiomyopathy: Etiology and Pathogenesis. , 2016, Current pharmaceutical design.

[50]  Jose H. Flores-Arredondo,et al.  Full Expression of Cardiomyopathy Is Partly Dependent on B‐Cells: A Pathway That Involves Cytokine Activation, Immunoglobulin Deposition, and Activation of Apoptosis , 2016, Journal of the American Heart Association.

[51]  J. Ouyang,et al.  lncRNAs regulate the innate immune response to viral infection , 2015, Wiley interdisciplinary reviews. RNA.

[52]  Honglin Luo,et al.  Cardiac Gab1 deletion leads to dilated cardiomyopathy associated with mitochondrial damage and cardiomyocyte apoptosis , 2015, Cell Death and Differentiation.

[53]  Dan J Stein,et al.  Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 , 2015, The Lancet.

[54]  S. Paludan,et al.  Catching the adaptor—WDFY1, a new player in the TLR–TRIF pathway , 2015, EMBO reports.

[55]  B. Morris,et al.  FOXO3: A Major Gene for Human Longevity - A Mini-Review , 2015, Gerontology.

[56]  D. Mann,et al.  Role of innate and adaptive immune mechanisms in cardiac injury and repair , 2015, Nature Reviews Immunology.

[57]  Qiuxi Zhou,et al.  IL-22-producing Th22 cells play a protective role in CVB3-induced chronic myocarditis and dilated cardiomyopathy by inhibiting myocardial fibrosis , 2014, Virology Journal.

[58]  Bo Gao,et al.  Involvement of NLRP3 inflammasome in CVB3-induced viral myocarditis. , 2014, American journal of physiology. Heart and circulatory physiology.

[59]  N. Mackman,et al.  Roles of PAR1 and PAR2 in viral myocarditis. , 2014, Thrombosis research.

[60]  C. Scheibenbogen,et al.  Adiponectin promotes coxsackievirus B3 myocarditis by suppression of acute anti-viral immune responses , 2014, Basic Research in Cardiology.

[61]  H. Zeichhardt,et al.  Protease-activated receptor-2 regulates the innate immune response to viral infection in a coxsackievirus B3-induced myocarditis. , 2013, Journal of the American College of Cardiology.

[62]  U. Eriksson,et al.  Innate Immune Interleukin-1 Receptor–Associated Kinase 4 Exacerbates Viral Myocarditis by Reducing CCR5+CD11b+ Monocyte Migration and Impairing Interferon Production , 2013, Circulation.

[63]  K. O’Shea,et al.  Radical Roles for RAGE in the Pathogenesis of Oxidative Stress in Cardiovascular Diseases and Beyond , 2013, International journal of molecular sciences.

[64]  Honglin Luo,et al.  Cleavage of sequestosome 1/p62 by an enteroviral protease results in disrupted selective autophagy and impaired NFKB signaling , 2013, Autophagy.

[65]  A. Casadevall,et al.  Innate Signaling Promotes Formation of Regulatory Nitric Oxide–Producing Dendritic Cells Limiting T-Cell Expansion in Experimental Autoimmune Myocarditis , 2013, Circulation.

[66]  D. Kirchhofer,et al.  PAR-1 contributes to the innate immune response during viral infection. , 2013, The Journal of clinical investigation.

[67]  C. Dong,et al.  Toll-like receptor 4 signaling in T cells promotes autoimmune inflammation , 2012, Proceedings of the National Academy of Sciences.

[68]  Wei Liu,et al.  IL-21R EXPRESSION ON CD8+T CELLS PROMOTES CD8+T CELL ACTIVATION IN COXSACKIEVIRUS B3 INDUCED MYOCARDITIS , 2012, Heart.

[69]  K. Klingel,et al.  Long-term follow-up of biopsy-proven viral myocarditis: predictors of mortality and incomplete recovery. , 2012, Journal of the American College of Cardiology.

[70]  Sandeep Sagar,et al.  Myocarditis , 2012, The Lancet.

[71]  H. Volk,et al.  Expression of functional T‐cell markers and T‐cell receptor Vbeta repertoire in endomyocardial biopsies from patients presenting with acute myocarditis and dilated cardiomyopathy , 2011, European journal of heart failure.

[72]  W. Leonard,et al.  Intrinsic IL-21 Signaling Is Critical for CD8 T Cell Survival and Memory Formation in Response to Vaccinia Viral Infection , 2011, The Journal of Immunology.

[73]  P. Sansonetti,et al.  NLR functions beyond pathogen recognition , 2011, Nature Immunology.

[74]  Xiang Cheng,et al.  Th17 Cells Contribute to Viral Replication in Coxsackievirus B3-Induced Acute Viral Myocarditis , 2010, The Journal of Immunology.

[75]  Xiaomin Wang,et al.  Prevention of Cardiac Dysfunction in Acute Coxsackievirus B3 Cardiomyopathy by Inducible Expression of a Soluble Coxsackievirus-Adenovirus Receptor , 2009, Circulation.

[76]  N. Lévêque,et al.  Viral causes of human myocarditis. , 2009, Archives of cardiovascular diseases.

[77]  Kirk U. Knowlton,et al.  Viral Myocarditis: From the Perspective of the Virus , 2009, Circulation.

[78]  J. Marvel,et al.  TLR2 Engagement on CD8 T Cells Enables Generation of Functional Memory Cells in Response to a Suboptimal TCR Signal1 , 2009, The Journal of Immunology.

[79]  K. Honda,et al.  A critical link between Toll-like receptor 3 and type II interferon signaling pathways in antiviral innate immunity , 2008, Proceedings of the National Academy of Sciences.

[80]  H. Ljunggren,et al.  IFN‐γ production dominates the early human natural killer cell response to Coxsackievirus infection , 2007, Cellular microbiology.

[81]  Shizuo Akira,et al.  Signaling to NF-?B by Toll-like receptors , 2007 .

[82]  G. Sen,et al.  A critical role for IRAK4 kinase activity in Toll-like receptor–mediated innate immunity , 2007, The Journal of experimental medicine.

[83]  M. Colonna.  TLR pathways and IFN‐regulatory factors: To each its own , 2007, European journal of immunology.

[84]  Shizuo Akira,et al.  Signaling to NF-kappaB by Toll-like receptors. , 2007, Trends in molecular medicine.

[85]  Dudley J Pennell,et al.  Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy. , 2006, Journal of the American College of Cardiology.

[86]  D. Littman,et al.  The Orphan Nuclear Receptor RORγt Directs the Differentiation Program of Proinflammatory IL-17+ T Helper Cells , 2006, Cell.

[87]  D. Littman,et al.  The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. , 2006, Cell.

[88]  A. Moss,et al.  Contemporary Definitions and Classification of the Cardiomyopathies , 2006 .

[89]  C. Janeway,et al.  Innate immune recognition. , 2002, Annual review of immunology.

[90]  Michael G. Rossmann,et al.  Interaction of coxsackievirus B3 with the full length coxsackievirus-adenovirus receptor , 2001, Nature Structural Biology.